Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. - Wikidata - awgldk - TriplyDB

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

http://www.wikidata.org/entity/Q34133511

about

Eosinophilic myeloproliferative disorders Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.Mast cell tryptase and carboxypeptidase A expression in body fluid and gastrointestinal tract associated with drug-related fatal anaphylaxis.Mast cell activation syndrome as a significant comorbidity in sickle cell disease.Mastocytosis: state of the art.Diagnosis and treatment of mast cell disorders: practical recommendations.Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome Diagnosis and treatment of systemic mastocytosis: state of the art.IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.Determination of plasma heparin level improves identification of systemic mast cell activation disease Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia Osteoporosis and osteopathy markers in patients with mastocytosis.Mastocytosis: pathology, genetics, and current options for therapy.Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis.The serum tryptase test: an emerging robust biomarker in clinical hematology.The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease.Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis Food allergy in adults: an over- or underrated problem?Tryptase as an inflammatory marker in allergic disease and asthma.Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.Clinical aspects of paediatric mastocytosis: a review of 101 cases.Current state of biology and diagnosis of clonal mast cell diseases in adults.Diagnosis, progression patterns and prognostication in mastocytosis.Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders Current concepts on diagnosis and treatment of mastocytosis.Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.Cutaneous mastocytosis extending beyond a radiotherapy site: a form of radiodermatitis or a neoplastic phenomenon?How we diagnose and treat systemic mastocytosis in adults.Mastocytosis - pathogenesis, clinical manifestation and treatment.Mastozytose - Pathogenese, Klinik und Therapie.Evaluation of the WHO criteria for the classification of patients with mastocytosis.Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.

P2860

Q33881283-75883EF2-683B-4F28-BAB5-CF0682D9E1F7 Q34293285-05603D42-79E5-429B-8FB7-E912F906DA90 Q34506923-26A755CA-744F-4CED-AAC1-646687908655 Q34564293-CCFAF33C-7888-43CE-B62D-6D0A55812747 Q34641105-851C8CE3-14CC-4FDA-991A-722A2BFC7808 Q35021196-ED028602-7FBE-47F7-A641-7479C3E43F49 Q35025246-1C260A29-CFDC-483A-9D60-78C6CDEDC115 Q35203889-19072D43-E18D-4945-8580-D6D779CCB5DA Q35490676-A6A83464-150C-4D8C-9F16-8915D7B61B9C Q35536695-A80186F1-E4D9-4521-89C5-E2CA2DC87581 Q35550174-1D77311A-D7CC-4C4A-A028-CBC0FE944B7E Q35631552-967442CD-8B8A-4E7D-93CF-DB03594582C1 Q35994902-FBC59E9A-BD22-41BC-BE26-32F010C75234 Q36128032-04EDB201-EF37-49C4-9AA1-DF9ACAD939EF Q36154674-48F01749-0272-4FF8-A90F-E3A7F74ADB64 Q36977305-FDE625FE-DEF8-4317-97C9-AFE8FF95A019 Q37174205-5649E65D-7869-4F95-BBD8-9A0D991754B0 Q37228933-C0AD83BE-59B0-4056-8C76-26A04C6EAD4A Q37755301-EF730681-1275-4357-89A6-6CEA8F27CCCC Q37810130-803DE3DB-BFAE-4533-ACDE-A110174E05A2 Q37876117-688AC446-4CB6-4C6C-9F0B-7305EADA8D86 Q37962614-17D95205-0D62-42D9-B0EF-51D09F249697 Q38007005-64817E25-9884-41EF-858F-7940A810DCF0 Q38025156-7B4F3854-F6BA-4423-BE6B-5AFDA9C10790 Q38202204-B71CA090-5B51-4269-8042-B7EDB6B3372C Q38978981-75317ACB-FBB3-4A54-BCD4-48204A752D3E Q39089887-91EC955A-259B-41DE-924F-CD8D8C10DE37 Q40456177-DEDB9CBF-59DB-4CF5-AB83-4CFDA17C96B6 Q41515301-9B3FD540-A995-45AA-9787-8CD3FAB92AB2 Q45730180-E43EC8CD-2D84-4B30-A48B-2A6D4E3C484D Q46533691-F84CEF25-681C-4899-B58D-8BF23BD04859 Q47763014-86E3A08F-8BFB-4B80-A635-F4DEF803B8D7 Q50122626-4E6BDABD-07A2-4CAA-95EC-9D1E2BC7CDDE Q50122660-66FC15C7-6C55-4386-B643-6C2484DBB97A Q51571187-DEB81EEA-C496-42CB-BE5F-0C3288962C76 Q52673481-C17F0825-8810-4541-A63D-7710CFF3E518 Q52731268-CD896F3A-F680-4F74-8489-EF229360A31C Q52935802-5B44B541-4037-4A49-AF68-4B31AE700FE5

P2860

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

http://www.wikidata.org/entity/Q34133511

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Serum tryptase levels in patie ...... ining the category of disease.

@ast

Serum tryptase levels in patie ...... ining the category of disease.

@en

Serum tryptase levels in patie ...... ining the category of disease.

@nl

type

label

Serum tryptase levels in patie ...... ining the category of disease.

@ast

Serum tryptase levels in patie ...... ining the category of disease.

@en

Serum tryptase levels in patie ...... ining the category of disease.

@nl

prefLabel

Serum tryptase levels in patie ...... ining the category of disease.

@ast

Serum tryptase levels in patie ...... ining the category of disease.

@en

Serum tryptase levels in patie ...... ining the category of disease.

@nl

P1433

Q34133511-8AA49B66-49DD-4757-AB13-C748E440C077

P1476

Q34133511-16FA3B53-945D-4394-B22F-40123198906F

P2093

Q34133511-21E8F183-DB79-4108-A220-ECB3076FB018

Q34133511-3F402C7F-45C2-48C1-9041-0C81DC89BD50

Q34133511-4E38CEC0-B10F-4DDD-8D98-56651EAE6371

Q34133511-5F3B697C-7390-4CEE-9DF9-E2689F68E8E6

Q34133511-6188C8CB-80FA-4180-85AB-AE130AC9BE2D

Q34133511-A346F0A3-4706-41D4-B45A-D35C2F5870EF

Q34133511-AFAE0617-401A-47ED-BFE0-499887A37301

Q34133511-C6AB694B-937D-4B5F-8DA0-7EA1ECD4AA7D

Q34133511-FF5CDBB0-1539-4610-9357-7F86427950ED

P304

Q34133511-8509DED8-7065-4538-8ACA-9B6EFD1BAE69

P31

Q34133511-F01E47E8-D3E2-4115-98F3-1D5EC2813FA9

P356

Q34133511-FFEB4782-DC8D-44AB-8F38-0A984F29DC08

P433

Q34133511-A6E3D41F-2243-4B89-90E7-7693EC41AB16

P478

Q34133511-872557B3-220D-4D11-9E15-AAC825ECC4F8

P50

Q34133511-D49B3D0F-1916-4779-98A6-B53F41ED10EC

P577

Q34133511-DADB2ED5-CB20-44D9-8567-4BF3E7AF4211

P698

Q34133511-DB4CEA45-9E75-4ED3-B1F5-6731F17E9736

P921

Q34133511-577DA0CD-6EE2-4C7E-A849-244A0A66E43E

Q34133511-AF496AF5-7060-47A1-9C0B-A5D85DBB627D

P356

P1433

International Archives of Allergy and Immunology

P1476

Serum tryptase levels in patie ...... fining the category of disease

@en

P2093

Carmen Bellas

http://www.w3.org/2001/XMLSchema#string

Hans Semper

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Horny

http://www.w3.org/2001/XMLSchema#string

Ingrid Simonitsch-Klupp

http://www.w3.org/2001/XMLSchema#string

John-Hendrik Jordan

http://www.w3.org/2001/XMLSchema#string

Luis Escribano

http://www.w3.org/2001/XMLSchema#string

Michael Fiegl

http://www.w3.org/2001/XMLSchema#string

Stephan Dirnhofer

http://www.w3.org/2001/XMLSchema#string

Wolfgang R Sperr

http://www.w3.org/2001/XMLSchema#string

P304

136-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000059404

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12065914

http://www.w3.org/2001/XMLSchema#string

P921